We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




An Organism's Genetic Background Influences how Mutant Genes Are Expressed

By LabMedica International staff writers
Posted on 19 Aug 2013
Expression of a phenotype caused by a mutation in a gene or set of genes is heavily influenced by interactions among the other genes that make up the genome of the organism.

Investigators at Michigan State University (East Lansing, USA) worked with the fruit fly Drosophila melanogaster, an intensively studied model system for human genetic interactions.

They focused on a genetic mutation that alters the shape of fruit fly wings and discovered that about 75% of the time the individual fly's wild type genetic background affected the expression of the mutated gene. More...
This finding was published in the August 1, 2013, online edition of the journal PLOS Genetics.

"It has been known for a while that genetic mutations can modify each other's effects," said senior author Dr. Ian Dworkin, associate professor of zoology at Michigan State University. "And we also know that the subtle differences in an individual's genome—what scientists call wild type genetic background—also affects how mutations are manifested."

Many disorders with a suspected genetic component, such as cancer, asthma, or Parkinson's disease, have been linked to interactions between more than one set of genes. "Is it just the two pairs of genes that are interacting?" asked Dr. Dworkin. "Or is it that the two genes are interacting and then many other genes are modifying that reaction? This will help us understand how much complexity is involved."

Related Links:

Michigan State University




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
All-in-One Molecular System
AIO M160
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.